{
    "id": 28498,
    "fullName": "PIK3R1 K448_Y452del",
    "impact": "deletion",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "PIK3R1 K448_Y452del results in the deletion of five amino acids in the iSH2 domain of the Pik3r1 protein from amino acids 448 to 452 (PMID: 20713702). K448_Y452del has been identified in the scientific literature (PMID: 29636360), but has not been biochemically characterized and therefore, its effect on Pik3r1 protein function is unknown (PubMed, Mar 2019).",
            "references": [
                {
                    "id": 11742,
                    "pubMedId": 29636360,
                    "title": "A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29636360"
                },
                {
                    "id": 723,
                    "pubMedId": 20713702,
                    "title": "Cancer-derived mutations in the regulatory subunit p85alpha of phosphoinositide 3-kinase function through the catalytic subunit p110alpha.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20713702"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5295,
        "geneSymbol": "PIK3R1",
        "terms": [
            "PIK3R1",
            "AGM7",
            "GRB1",
            "IMD36",
            "p85",
            "p85-ALPHA"
        ]
    },
    "variant": "K448_Y452del",
    "createDate": "07/18/2018",
    "updateDate": "09/27/2019",
    "referenceTranscriptCoordinates": {
        "id": 184053,
        "transcript": "NM_181523",
        "gDna": "chr5:g.68293753_68293767del15",
        "cDna": "c.1344_1358del15",
        "protein": "p.K448_Y452delKLHEY",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 14556,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, LY3023414 treatment resulted in a disease control rate of 34% (16/47; 1 partial response, 15 stable disease) in patients with advanced solid tumors, with the partial response occurring in a patient with endometrial cancer harboring PIK3R1 K448_Y452del and PTEN L193fs (PMID: 29636360; NCT01655225).",
            "molecularProfile": {
                "id": 30242,
                "profileName": "PIK3R1 K448_Y452del PTEN L193fs"
            },
            "therapy": {
                "id": 1069,
                "therapyName": "LY3023414",
                "synonyms": null
            },
            "indication": {
                "id": 1380,
                "name": "endometrial cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 11742,
                    "pubMedId": 29636360,
                    "title": "A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29636360"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 30193,
            "profileName": "PIK3R1 K448_Y452del",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 30242,
            "profileName": "PIK3R1 K448_Y452del PTEN L193fs",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 184055,
            "transcript": "XM_017009586",
            "gDna": "chr5:g.68295195_68295209del15",
            "cDna": "c.1343_1357del15",
            "protein": "p.I448_R452delIDSRR",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 184057,
            "transcript": "NM_181504",
            "gDna": "chr5:g.68297578_68297592del15",
            "cDna": "c.1342_1356del15",
            "protein": "p.V448_Q452delVYAQQ",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 184054,
            "transcript": "XM_017009585",
            "gDna": "chr5:g.68293753_68293767del15",
            "cDna": "c.1344_1358del15",
            "protein": "p.K448_Y452delKLHEY",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 184052,
            "transcript": "XM_005248542",
            "gDna": "chr5:g.68293753_68293767del15",
            "cDna": "c.1344_1358del15",
            "protein": "p.K448_Y452delKLHEY",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 184053,
            "transcript": "NM_181523",
            "gDna": "chr5:g.68293753_68293767del15",
            "cDna": "c.1344_1358del15",
            "protein": "p.K448_Y452delKLHEY",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 184056,
            "transcript": "XM_011543493",
            "gDna": "chr5:g.68295250_68295264del15",
            "cDna": "c.1344_1358del15",
            "protein": "p.E449_R453delEIDKR",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}